Sevoflurane and Isoflurane-Pharmacokinetics, Hemodynamic Stability, and Cardioprotective Effects During Cardiopulmonary Bypass

J Cardiothorac Vasc Anesth. 2016 Dec;30(6):1494-1501. doi: 10.1053/j.jvca.2016.07.011. Epub 2016 Jul 12.

Abstract

Objectives: This study aimed to evaluate the pharmacokinetic profiles of sevoflurane and isoflurane during use of minimized extracorporeal circulation to perform coronary artery bypass graft surgery. Furthermore, cardiovascular stability during bypass and the postoperative release of troponins were evaluated.

Design: Prospective, randomized study.

Setting: University hospital.

Participants: The study comprised 31 adult patients undergoing coronary artery bypass grafting.

Interventions: The pharmacokinetic measurements of the concentration of the volatile anesthetics in the arterial and venous blood, air inlet, air outlet, and gas exhaust of the extracorporeal circulation were recorded. Secondary end-points were cardiovascular stability during bypass, amount of postoperative release of troponin, time to extubation, time to discharge from the intensive care unit and the hospital, and 30-day mortality.

Measurements and main results: Thirty patients completed the protocol. The pharmacokinetics of isoflurane and sevoflurane were almost identical, with a rapid wash-in (time to reach 50% of arterial steady state) concentration of 0.87±0.97 minutes and 1.14±0.35 minutes for isoflurane and sevoflurane, respectively, and a biphasic venous elimination with a terminal half-life of approximately 10 minutes for both compounds. There was a correlation between the gas inlet and the gas exhaust of the extracorporeal circulation. No difference in cardiovascular stability was found. High-sensitivity troponin concentrations on the first postoperative morning were 0.355±0.312 µg/mL and 0.225±0.111 µg/mL in the isoflurane and sevoflurane groups, respectively (p = 0.147).

Conclusions: The study found similar pharmacokinetics regarding wash-in and wash-out for sevoflurane and isoflurane. In addition, no difference in cardiovascular stability was found. The markers of cardiac damage were not different between the two anesthetics. Based on these data, sevoflurane and isoflurane might be used equivalently in patients undergoing coronary artery bypass graft surgery with extracorporeal circulation.

Keywords: cardioprotective effects; hemodynamic effects; isoflurane; minimized extracorporeal cardiopulmonary bypass; pharmacokinetics; sevoflurane; volatile anesthetics.

Publication types

  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Aged
  • Anesthetics, Inhalation / blood*
  • Anesthetics, Inhalation / pharmacology
  • Cardiopulmonary Bypass / adverse effects
  • Cardiopulmonary Bypass / methods*
  • Cardiotonic Agents / blood*
  • Cardiotonic Agents / pharmacology
  • Coronary Artery Bypass / adverse effects
  • Coronary Artery Bypass / methods
  • Double-Blind Method
  • Female
  • Half-Life
  • Hemodynamics / drug effects
  • Humans
  • Isoflurane / blood*
  • Isoflurane / pharmacology
  • Length of Stay / statistics & numerical data
  • Male
  • Methyl Ethers / blood*
  • Methyl Ethers / pharmacology
  • Middle Aged
  • Prospective Studies
  • Sevoflurane
  • Troponin T / blood

Substances

  • Anesthetics, Inhalation
  • Cardiotonic Agents
  • Methyl Ethers
  • Troponin T
  • Sevoflurane
  • Isoflurane